{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:16:20Z","timestamp":1771028180776,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.lfs.2006.10.002","type":"journal-article","created":{"date-parts":[[2006,11,2]],"date-time":"2006-11-02T23:26:43Z","timestamp":1162510003000},"page":"566-572","source":"Crossref","is-referenced-by-count":17,"title":["Neuropharmacological profile of FrPbAII, purified from the venom of the social spider Parawixia bistriata (Araneae, Araneidae), in Wistar rats"],"prefix":"10.1016","volume":"80","author":[{"given":"Erica Aparecida","family":"Gelfuso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra Olimpio Siqueira","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia Renata","family":"Mortari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luiz","family":"Liberato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina Haddad","family":"Paraventi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rene Oliveira","family":"Beleboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim","family":"Coutinho-Netto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norberto Peporine","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wagner Ferreira","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2006.10.002_bib1","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1016\/S0968-0896(01)00148-1","article-title":"Synthesis of novel GABA uptake inhibitors. Part 6: preparation and evaluation of N\u2013W asymmetrically substituted nipecotic acid derivatives","volume":"9","author":"Andersen","year":"2001","journal-title":"Bioorganic and Medicinal Chemistry"},{"issue":"6","key":"10.1016\/j.lfs.2006.10.002_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10571-004-6913-z","article-title":"Pharmacological and biochemical aspects of GABAergic neurotransmission: pathological and neuropsycobiological relationships","volume":"24","author":"Beleboni","year":"2004","journal-title":"Cellular and Molecular Neurobiology"},{"key":"10.1016\/j.lfs.2006.10.002_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2004.03.049","article-title":"Spider and wasp neurotoxins: pharmacological and biochemical aspects","volume":"17","author":"Beleboni","year":"2004","journal-title":"European Journal of Pharmacology"},{"issue":"6","key":"10.1016\/j.lfs.2006.10.002_bib4","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1124\/mol.105.017319","article-title":"Neurochemical characterization of a neuroprotective compound from Parawixia bistriata spider venom that inhibits synaptosomal uptake of GABA and glycine","volume":"69","author":"Beleboni","year":"2006","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.lfs.2006.10.002_bib5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1076\/phbi.40.6.472.8436","article-title":"P. bistriata and S. raptoria venoms: inhibition of GABA uptake and convulsant effect","volume":"40","author":"Cairr\u00e3o","year":"2002","journal-title":"Pharmaceutical Biology"},{"issue":"3\u20134","key":"10.1016\/j.lfs.2006.10.002_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0014-2999(83)90497-1","article-title":"Anticonvulsant activity of GABA uptake inhibitors and their prodrugs following central or systemic administration","volume":"89","author":"Croucher","year":"1983","journal-title":"European Journal of Pharmacology"},{"issue":"12","key":"10.1016\/j.lfs.2006.10.002_bib7","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0028-3908(00)00075-7","article-title":"GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors","volume":"39","author":"Dalby","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2006.10.002_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2003.08.063","article-title":"Inhibition of y-aminobutyric acid uptake: anatomy, physiology and effects against epileptic seizures","volume":"479","author":"Dalby","year":"2003","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.lfs.2006.10.002_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-1211(97)00033-8","article-title":"Anticonvulsant properties of two GABA uptake inhibitors NNC 05-2045 and NNC 05-2090, not acting preferentially on GAT-1","volume":"28","author":"Dalby","year":"1997","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.lfs.2006.10.002_bib10","series-title":"Probit Analysis","first-page":"368","author":"Finney","year":"1971"},{"key":"10.1016\/j.lfs.2006.10.002_bib11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/jnr.1040","article-title":"Glial transporters for glutamate, glycine and GABA. II: GABA transporters","volume":"63","author":"Gadea","year":"2001","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.lfs.2006.10.002_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0387-7604(99)00113-8","article-title":"When antiepileptic drugs aggravate epilepsy","volume":"22","author":"Genton","year":"2000","journal-title":"Brain and Development"},{"issue":"Suppl. 9","key":"10.1016\/j.lfs.2006.10.002_bib13","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1111\/j.1528-1157.1997.tb05203.x","article-title":"The problem of intractability: the continuing need for new medical therapies in epilepsy","volume":"38","author":"Jallon","year":"1997","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.lfs.2006.10.002_bib14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1471-4159.1975.tb04410.x","article-title":"Inhibition of GABA uptake in rat brain slices by nipecotic acid, various isoxazoles and related compounds","volume":"25","author":"Krogsgaard-Larsen","year":"1975","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.lfs.2006.10.002_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0163-7258(01)00122-X","article-title":"The mechanisms of commonly used antiepileptic drugs","volume":"90","author":"Kwan","year":"2001","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.lfs.2006.10.002_bib16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1006\/ebeh.2000.0085","article-title":"Consequences of pentylenotetrazole-induced kindling on spational memory and emotional responding in the rat","volume":"1","author":"Lamberty","year":"2000","journal-title":"Epilepsy and Behavior"},{"issue":"5","key":"10.1016\/j.lfs.2006.10.002_bib17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.291.5.605","article-title":"The new antiepileptic drugs: scientific review","volume":"291","author":"LaRoche","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.lfs.2006.10.002_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(97)01514-8","article-title":"New visions in the pharmacology of anticonvulsion. Review","volume":"342","author":"L\u00f6scher","year":"1998","journal-title":"European Journal of Pharmacology"},{"issue":"Suppl. 9","key":"10.1016\/j.lfs.2006.10.002_bib19","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1111\/j.1528-1157.1997.tb05204.x","article-title":"Identification and preclinical testing of novel antiepileptic compounds","volume":"38","author":"Meldrum","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.lfs.2006.10.002_bib20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.toxicon.2004.02.003","article-title":"Targeting ionotropic receptors with polyamine-containing toxins","volume":"43","author":"Mellor","year":"2004","journal-title":"Toxicon"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2006.10.002_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)02149-6","article-title":"Glutamate metabotropic receptors as targets for drug therapy in epilepsy","volume":"22;476","author":"Moldrich","year":"2003","journal-title":"European Journal of Pharmacology"},{"issue":"24","key":"10.1016\/j.lfs.2006.10.002_bib22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/297681a0","article-title":"Place navigation impaired in rats with hippocampal lesions","volume":"297","author":"Morris","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2006.10.002_bib23","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"issue":"2","key":"10.1016\/j.lfs.2006.10.002_bib24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0014-4886(78)90133-4","article-title":"Experimental epileptogenesis; kindling-induced epilepsy in rats","volume":"58","author":"Pinel","year":"1978","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.lfs.2006.10.002_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0378-8741(01)00327-0","article-title":"Anticonvulsant activities of ethanolic extract and aqueous fraction isolated from Delphinium denudatum","volume":"78","author":"Raza","year":"2001","journal-title":"Journal of Ethnopharmacology"},{"issue":"2","key":"10.1016\/j.lfs.2006.10.002_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00008877-199903000-00002","article-title":"Effects of GABA-transporter (GAT) inhibitors on rat behaviour in open-field and elevated plus-maze","volume":"10","author":"Schmitt","year":"1999","journal-title":"Behavioural Pharmacology"},{"issue":"8","key":"10.1016\/j.lfs.2006.10.002_bib27","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.bcp.2004.06.041","article-title":"GABA transporters as drug targets for modulation of GABAergic activity","volume":"68","author":"Schousboe","year":"2004","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.lfs.2006.10.002_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF00229142","article-title":"Bicuculline-induced circling from the rat superior colliculus is blocked by GABA microinjection into deep cerebellar nuclei","volume":"110","author":"Speller","year":"1996","journal-title":"Experimental Brain Research"},{"key":"10.1016\/j.lfs.2006.10.002_bib29","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1528-1157.1995.tb02576.x","article-title":"A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor","volume":"36","author":"Suzdak","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.lfs.2006.10.002_bib30","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0028-3908(01)00026-0","article-title":"Preclinical evaluation of CHF3381 as a novel antiepileptic agent","volume":"40","author":"Villetti","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2006.10.002_bib31","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1124\/jpet.102.034819","article-title":"Correlation between anticonvulsant activity and inhibitory action on glial GABA uptake of the highly selective mouse Gat1 inhibitor 3-Hydroxy-4-Amino-4,5,6,7-Tetrahydro-12-Benzisoxazole (Exo-Thpo) and its N-Alkylated analogs","volume":"302","author":"White","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320506007867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320506007867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T18:56:40Z","timestamp":1547233000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320506007867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0024320506007867"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2006.10.002","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}